192 related articles for article (PubMed ID: 23689009)
21. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus.
Makara JK; Mor M; Fegley D; Szabó SI; Kathuria S; Astarita G; Duranti A; Tontini A; Tarzia G; Rivara S; Freund TF; Piomelli D
Nat Neurosci; 2005 Sep; 8(9):1139-41. PubMed ID: 16116451
[TBL] [Abstract][Full Text] [Related]
22. Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo.
Bisogno T; Ortar G; Petrosino S; Morera E; Palazzo E; Nalli M; Maione S; Di Marzo V;
Biochim Biophys Acta; 2009 Jan; 1791(1):53-60. PubMed ID: 19027877
[TBL] [Abstract][Full Text] [Related]
23. Impact of tetrahydrocannabinol on the endocannabinoid 2-arachidonoylglycerol metabolism: ABHD6 and ABHD12 as novel players in human placenta.
Maia J; Fonseca BM; Cunha SC; Braga J; Gonçalves D; Teixeira N; Correia-da-Silva G
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158807. PubMed ID: 32829065
[TBL] [Abstract][Full Text] [Related]
24. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
Ueda N; Tsuboi K; Uyama T; Ohnishi T
Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
[TBL] [Abstract][Full Text] [Related]
25. Brain monoglyceride lipase participating in endocannabinoid inactivation.
Dinh TP; Carpenter D; Leslie FM; Freund TF; Katona I; Sensi SL; Kathuria S; Piomelli D
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10819-24. PubMed ID: 12136125
[TBL] [Abstract][Full Text] [Related]
26. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes.
Saario SM; Savinainen JR; Laitinen JT; Järvinen T; Niemi R
Biochem Pharmacol; 2004 Apr; 67(7):1381-7. PubMed ID: 15013854
[TBL] [Abstract][Full Text] [Related]
27. Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Biofactors; 2013; 39(2):209-20. PubMed ID: 23281018
[TBL] [Abstract][Full Text] [Related]
28. Mutation of Cys242 of human monoacylglycerol lipase disrupts balanced hydrolysis of 1- and 2-monoacylglycerols and selectively impairs inhibitor potency.
Laitinen T; Navia-Paldanius D; Rytilahti R; Marjamaa JJ; Kařízková J; Parkkari T; Pantsar T; Poso A; Laitinen JT; Savinainen JR
Mol Pharmacol; 2014 Mar; 85(3):510-9. PubMed ID: 24368842
[TBL] [Abstract][Full Text] [Related]
29. Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol.
Saario SM; Laitinen JT
Chem Biodivers; 2007 Aug; 4(8):1903-13. PubMed ID: 17712832
[No Abstract] [Full Text] [Related]
30. Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase.
Vandevoorde S; Saha B; Mahadevan A; Razdan RK; Pertwee RG; Martin BR; Fowler CJ
Biochem Biophys Res Commun; 2005 Nov; 337(1):104-9. PubMed ID: 16181610
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.
Blankman JL; Simon GM; Cravatt BF
Chem Biol; 2007 Dec; 14(12):1347-56. PubMed ID: 18096503
[TBL] [Abstract][Full Text] [Related]
32. Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin.
Schopfer LM; Lockridge O; Brimijoin S
Gen Comp Endocrinol; 2015 Dec; 224():61-8. PubMed ID: 26073531
[TBL] [Abstract][Full Text] [Related]
33. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
34.
Klawitter J; Weissenborn W; Gvon I; Walz M; Klawitter J; Jackson M; Sempio C; Joksimovic SL; Shokati T; Just I; Christians U; Todorovic SM
Mol Pharmacol; 2024 Jan; 105(2):75-83. PubMed ID: 38195158
[TBL] [Abstract][Full Text] [Related]
35. A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).
Granchi C; Caligiuri I; Minutolo F; Rizzolio F; Tuccinardi T
Expert Opin Ther Pat; 2017 Dec; 27(12):1341-1351. PubMed ID: 29053063
[TBL] [Abstract][Full Text] [Related]
36. Impact of Fabp1 Gene Ablation on Uptake and Degradation of Endocannabinoids in Mouse Hepatocytes.
McIntosh AL; Huang H; Landrock D; Martin GG; Li S; Kier AB; Schroeder F
Lipids; 2018 Jun; 53(6):561-580. PubMed ID: 30203570
[TBL] [Abstract][Full Text] [Related]
37. Assay of Endocannabinoid Oxidation by Cyclooxygenase-2.
Kudalkar SN; Kingsley PJ; Marnett LJ
Methods Mol Biol; 2016; 1412():205-15. PubMed ID: 27245906
[TBL] [Abstract][Full Text] [Related]
38. Human leukocytes differentially express endocannabinoid-glycerol lipases and hydrolyze 2-arachidonoyl-glycerol and its metabolites from the 15-lipoxygenase and cyclooxygenase pathways.
Turcotte C; Dumais É; Archambault AS; Martin C; Blanchet MR; Bissonnette É; Boulet LP; Laviolette M; Di Marzo V; Flamand N
J Leukoc Biol; 2019 Dec; 106(6):1337-1347. PubMed ID: 31556464
[TBL] [Abstract][Full Text] [Related]
39. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system.
Chanda PK; Gao Y; Mark L; Btesh J; Strassle BW; Lu P; Piesla MJ; Zhang MY; Bingham B; Uveges A; Kowal D; Garbe D; Kouranova EV; Ring RH; Bates B; Pangalos MN; Kennedy JD; Whiteside GT; Samad TA
Mol Pharmacol; 2010 Dec; 78(6):996-1003. PubMed ID: 20855465
[TBL] [Abstract][Full Text] [Related]
40. Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism.
Ortar G; Bisogno T; Ligresti A; Morera E; Nalli M; Di Marzo V
J Med Chem; 2008 Nov; 51(21):6970-9. PubMed ID: 18831576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
